Peripheral T-cell Lymphoma NOS
4 clinical trials · Condition
◉ Watch Peripheral T-cell Lymphoma NOS
| Record | Firm | Date |
|---|---|---|
| Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies (NCT03905135) | National Cancer Institute (NCI) | 2019-06-07 |
| Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms (NCT03493451) | BeiGene | 2018-04-13 |
| CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma (NCT02742727) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2016-03-01 |
| CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study (NCT01719835) | Royal Marsden NHS Foundation Trust | 2012-03-01 |
Track Peripheral T-cell Lymphoma NOS automatically
Every clearance here is in the API, with alerts when new ones post.